153 related articles for article (PubMed ID: 2413929)
1. Prognostic value of estrogen receptors determined by radiochemical vs. histochemical methods in breast cancer.
Sismondi P; Aimone V; Genta F; Voglino G; Deltetto F; Giardina G; Botta G; Ghiringhello B; Mano MP; Zola P
Breast Cancer Res Treat; 1985; 6(1):67-73. PubMed ID: 2413929
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance.
Layfield LJ; Saria EA; Conlon DH; Kerns BJ
J Surg Oncol; 1996 Mar; 61(3):177-84. PubMed ID: 8637203
[TBL] [Abstract][Full Text] [Related]
4. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
5. Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma.
Fisher ER; Anderson S; Dean S; Dabbs D; Fisher B; Siderits R; Pritchard J; Pereira T; Geyer C; Wolmark N
Cancer; 2005 Jan; 103(1):164-73. PubMed ID: 15565575
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis.
Chevallier B; Heintzmann F; Mosseri V; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M; Asselain B
Cancer; 1988 Dec; 62(12):2517-24. PubMed ID: 3191451
[TBL] [Abstract][Full Text] [Related]
8. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
Schenck U; Jütting U; Eiermann W
Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
[TBL] [Abstract][Full Text] [Related]
9. Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials.
Alberts SR; Ingle JN; Roche PR; Cha SS; Wold LE; Farr GH; Krook JE; Wieand HS
Cancer; 1996 Aug; 78(4):764-72. PubMed ID: 8756370
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
[TBL] [Abstract][Full Text] [Related]
12. [Cancer of the breast and the receptor status].
Buonomo O; Serao A; Muggianu A; Guglielmelli E; Davoli E; Amori A
G Chir; 1991 Apr; 12(4):274-7. PubMed ID: 1911078
[TBL] [Abstract][Full Text] [Related]
13. Comparison of standardized immunohistochemical and biochemical assays for estrogen and progesterone receptors in breast carcinoma.
Golouh R; Vrhovec I; Bracko M; Frković-Grazio S
Pathol Res Pract; 1997; 193(8):543-9. PubMed ID: 9406247
[TBL] [Abstract][Full Text] [Related]
14. Breast cancers negative for estrogen receptor but positive for progesterone receptor, a true entity?
Kiang DT; Kollander R
J Clin Oncol; 1987 Apr; 5(4):662-6. PubMed ID: 2435857
[TBL] [Abstract][Full Text] [Related]
15. Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences.
Ruder AM; Lubin F; Wax Y; Geier A; Alfundary E; Chetrit A
Cancer; 1989 Jul; 64(1):196-202. PubMed ID: 2731116
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
[TBL] [Abstract][Full Text] [Related]
17. [Estradiol and progesterone receptors in loco-regional breast cancer. Clinical and prognostic correlations].
Bolla M; Chedin M; Chambaz E; Gabelle P
Sem Hop; 1984 Jan; 60(2):91-6. PubMed ID: 6322331
[TBL] [Abstract][Full Text] [Related]
18. [Comparative studies of estrogen receptor determinations by enzyme immuno-assay using the monoclonal antibody, dextran-coated charcoal, and sucrose density gradient methods].
Tominaga T; Yoshida Y; Kitamura M; Kosaki G
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1782-6. PubMed ID: 2412495
[TBL] [Abstract][Full Text] [Related]
19. Rising levels of estrogen receptor in breast cancer over 2 decades.
Pujol P; Hilsenbeck SG; Chamness GC; Elledge RM
Cancer; 1994 Sep; 74(5):1601-6. PubMed ID: 8062191
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features.
Nagai MA; Marques LA; Yamamoto L; Fujiyama CT; Brentani MM
Int J Cancer; 1994 Nov; 59(3):351-6. PubMed ID: 7927940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
